Jan 11, 2023 / 03:30PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Good morning, everyone. I'm Robbie Marcus, the medtech analyst at JPMorgan. Happy to kick off the third day of the conference Treace Medical. I'm going to turn it over to John Treace, the Founder and CEO, and then we'll do a bit of Q&A afterwards. John?
John T. Treace - Treace Medical Concepts, Inc. - CEO, Founder & Director
Thank you, Robbie, and good morning, everybody. We're really excited to be here and have the opportunity to talk about Treace Medical at the JPMorgan Healthcare Conference.
So Treace Medical is a high-growth med tech company, 100% focused on improving outcomes for bunion patients. We pioneered and patented the Lapiplasty 3D Bunion Correction procedure to bring better outcomes to patients suffering from painful lifestyle-limiting bunion deformities. Our business has shown strong momentum since our first commercial sale in 2015, and we recently preannounced 2022 revenues representing growth of 50% over prior year.
As a high-growth rate, high
Treace Medical Concepts Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers